Source: Annual Congress 2003 - Pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. V. Martynyuk, I. D. Konosova, N. A. Mironova, I. Y. Chazova (Moscow, Russia). Primary pulmonary hypertension and endothelial dysfunction. Eur Respir J 2003; 22: Suppl. 45, 3655

Member's Comments

No comment yet.

Related content which might interest you: Endothelial dysfunction of patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (2) 2101645; 10.1183/13993003.01645-2021 Year: 2021 Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Peripheral endothelial dysfunction in patients with pulmonary artery hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 344s Year: 2007 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Endothelial dysfunction and pulmonary hypertension in chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: cardiovascular comorbidities Year: 2010 Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension Year: 2021 Primary pulmonary hypertension, hyperuricaemia and renal function Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Endothelial NO and its pathophysiologic regulation Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016 Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004 Peripheral arterial stiffness and endothelial dysfunction in pulmonary arterial hypertension Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load Year: 2015 Assessment of platelet dysfunction in patients with pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Endothelial dysfunction in patients with bronchial asthma with and without arterial hypertension Source: Annual Congress 2009 - Asthma and comorbid conditions Year: 2009